(Q34443720)

2 August 2017

1 reference

title

B-type natriuretic peptide in the diagnosis and management of congestive heart failure (English)

1 reference

2 August 2017

0 references

congestive heart failure

1 reference

Maisel A

1

1 reference

2 August 2017

publication date

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

557-571

1 reference

ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in co

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Post hoc subgroup analysis and the truth of a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

How to diagnose diastolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Natriuretic peptides--relevance in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Predictors of readmission among elderly survivors of admission with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Clinical utility of transthoracic two-dimensional and Doppler echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Meta-analysis of Pap test accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Predictive properties of serum-prostate-specific antigen testing in a community-based setting

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Mechanisms and models in heart failure: A combinatorial approach

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Neuroendocrine activity in untreated heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Human and canine gene homologs of porcine brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Optimizing therapy for complex or refractory heart failure: a management algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Enhancing and evaluating diagnostic accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Early readmission of elderly patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Brain natriuretic peptide predicts mortality in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Effects of prehospital medications on mortality and length of stay in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Clinical criteria and biochemical markers for the detection of systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

Biochemistry of natriuretic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970243-5

7 January 2021

10.1016/S0733-8651(05)70243-5

Identifiers

DOI

1 reference

2 August 2017

1 reference